Lazard Asset Management LLC Day One Biopharmaceuticals, Inc. Transaction History
Lazard Asset Management LLC
- $63.4 Billion
- Q2 2025
A detailed history of Lazard Asset Management LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 13,765 shares of DAWN stock, worth $96,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,765Holding current value
$96,905% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
183Shares Held
70.5MCall Options Held
122KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$45.3 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$43.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$31.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$28.8 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$26.2 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $517M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...